1449136-52-0Relevant academic research and scientific papers
FUSED PYRROLEDICARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS
-
Page/Page column 118; 119, (2013/08/15)
The present invention relates to fused pyrroledicarboxamides of the formula (I), in which R1 to R9, X, m and n are as defined in the claims. The compounds of the formula (I) are inhibitors of the acid-sensitive potassium channel TASK-1 and suitable for the treatment of TASK-1 channel-mediated diseases such as arrhythmias, in particular atrial arrhythmias like atrial fibrillation or atrial flutter, and respiratory disorders, in particular sleep-related respiratory disorders like sleep apnea, for example.
